To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Zymeworks adopts poison pill to stop All Blue takeover: Reuters
Zymeworks said the shareholder rights plan would stop investors from amassing more than 10 percent of its share.
